PICO Portalanswers from OpenAlex & ORCID
Nicholas P. Restifo
ResearcherPublications, citations & collaboration network
Nicholas P. Restifo is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Nicholas P. Restifo have?
PICO Portalindexed works
Nicholas P. Restifo has 674 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nicholas P. Restifo have?
PICO Portalcitation count
Nicholas P. Restifo has 97,691 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Nicholas P. Restifo?
PICO Portalh-index
Nicholas P. Restifo has an h-index of 151 in OpenAlex.
What is the i10-index of Nicholas P. Restifo?
PICO Portali10-index
Nicholas P. Restifo has an i10-index of 361 in OpenAlex.
What is the OpenAlex record for Nicholas P. Restifo?
PICO Portalopenalex
The OpenAlex for Nicholas P. Restifo is on the source record.
What are the most-cited papers on Nicholas P. Restifo?
PICO Portalmost cited works
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Mark E. Dudley, Susan Schwarz, Paul J. Spiess, Maria R. Parkhurst, Yutaka Kawakami, Claudia A. Seipp, Jan Einhorn, Donald E. White
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg